Safety and Efficacy of Bimekizumab in Patients with Active Psoriatic Arthritis: \textsc3-\textscYear Results from a Phase 2b Randomized Controlled Trial and Its \textscOpen\textsc-\textscLabel Extension Study

Laura C. Coates; Iain B. Mcinnes; Joseph F. Merola; Richard B. Warren; Arthur Kavanaugh; Alice B. Gottlieb; Laure Gossec; Deepak Assudani; Rajan Bajracharya; Jason Coarse; Barbara Ink; Christopher T. Ritchlin

doi:10.1002/art.42280

Journal Articles Arthritis & Rheumatology Year : 2022

Safety and Efficacy of Bimekizumab in Patients with Active Psoriatic Arthritis: \textsc3-\textscYear Results from a Phase 2b Randomized Controlled Trial and Its \textscOpen\textsc-\textscLabel Extension Study

(1) , , , , (2) , , (3, 4) , , , , ,

1
2
3
4

Laura C. Coates

Function : Author

University of Oxford

Iain B. Mcinnes

Function : Author

Joseph F. Merola

Function : Author

Richard B. Warren

Function : Author

Arthur Kavanaugh

Function : Author

University of California [San Diego]

Alice B. Gottlieb

Function : Author

Laure Gossec

Function : Author

CHU Pitié-Salpêtrière [AP-HP]

Institut Pierre Louis d'Epidémiologie et de Santé Publique

Deepak Assudani

Function : Author

Rajan Bajracharya

Function : Author

Jason Coarse

Function : Author

Barbara Ink

Function : Author

Christopher T. Ritchlin

Function : Author

Domains

Life Sciences [q-bio]

Gestionnaire HAL 3 Sorbonne Université : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03894249

Submitted on : Monday, December 12, 2022-10:54:15 AM

Last modification on : Saturday, October 7, 2023-9:36:20 PM

Dates and versions

hal-03894249 , version 1 (12-12-2022)

Identifiers

HAL Id : hal-03894249 , version 1
DOI : 10.1002/art.42280

Cite

Laura C. Coates, Iain B. Mcinnes, Joseph F. Merola, Richard B. Warren, Arthur Kavanaugh, et al.. Safety and Efficacy of Bimekizumab in Patients with Active Psoriatic Arthritis: \textsc3-\textscYear Results from a Phase 2b Randomized Controlled Trial and Its \textscOpen\textsc-\textscLabel Extension Study. Arthritis & Rheumatology, 2022, pp.art.42280. ⟨10.1002/art.42280⟩. ⟨hal-03894249⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

IPLESP SORBONNE-UNIVERSITE SU-MEDECINE

8 View

0 Download

Safety and Efficacy of Bimekizumab in Patients with Active Psoriatic Arthritis: \textsc3-\textscYear Results from a Phase 2b Randomized Controlled Trial and Its \textscOpen\textsc-\textscLabel Extension Study

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share